These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17319450)

  • 21. Efficacy and safety of twice-daily tramadol hydrochloride bilayer sustained-release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double-blind, placebo-controlled, treatment-withdrawal study.
    Kawai S; Hasegawa J; Ito H; Fukuuchi Y; Nakano H; Ohtani H; Sasaki K; Adachi T
    Pain Pract; 2023 Mar; 23(3):277-289. PubMed ID: 36478501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
    Zuniga JR; Ibanez C; Kozacko M
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.
    Watson CP; Babul N
    Neurology; 1998 Jun; 50(6):1837-41. PubMed ID: 9633737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model.
    Korn S; Vassil TC; Kotey PN; Fricke JR
    Clin Ther; 2004 May; 26(5):769-78. PubMed ID: 15220020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.
    Raja SN; Haythornthwaite JA; Pappagallo M; Clark MR; Travison TG; Sabeen S; Royall RM; Max MB
    Neurology; 2002 Oct; 59(7):1015-21. PubMed ID: 12370455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.
    Gimbel JS; Brugger A; Zhao W; Verburg KM; Geis GS
    Clin Ther; 2001 Feb; 23(2):228-41. PubMed ID: 11293556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fixed nitrous oxide/oxygen mixture as an analgesic for patients with postherpetic neuralgia: study protocol for a randomized controlled trial.
    Gao HX; Zhang JJ; Liu N; Wang Y; Ma CX; Gao LL; Liu Q; Zhang TT; Wang YL; Bao WQ; Li YX
    Trials; 2021 Jan; 22(1):29. PubMed ID: 33407845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.
    Uberall MA; Mueller-Schwefe GH; Terhaag B
    Curr Med Res Opin; 2012 Oct; 28(10):1617-34. PubMed ID: 22970658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR
    Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal oxycodone patch for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled trial.
    Gavin PD; Tremper L; Smith A; Williams G; Brooker C
    Pain Manag; 2017 Jul; 7(4):255-267. PubMed ID: 28415907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
    Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM
    Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Webster LR; Malan TP; Tuchman MM; Mollen MD; Tobias JK; Vanhove GF
    J Pain; 2010 Oct; 11(10):972-82. PubMed ID: 20655809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
    Freeman R; Wallace MS; Sweeney M; Backonja MM
    Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.